Development of a single-chain, quasi-dimeric zinc-finger nuclease for the selective degradation of mutated human mitochondrial DNA.
about
Progress and prospects: zinc-finger nucleases as gene therapy agentsGenetic manipulation for inherited neurodegenerative diseases: myth or reality?Mitochondrial DNA disease-molecular insights and potential routes to a cureLiver-targeted gene therapy: Approaches and challengesZinc finger nucleases as tools to understand and treat human diseases.Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs.Re-engineering the mitochondrial genomes in mammalian cellsTherapeutic prospects for mitochondrial disease.Selective elimination of mitochondrial mutations in the germline by genome editingThe use of mitochondria-targeted endonucleases to manipulate mtDNAA single-chain TALEN architecture for genome engineering.The generation of zinc finger proteins by modular assembly.Organ-specific shifts in mtDNA heteroplasmy following systemic delivery of a mitochondria-targeted restriction endonuclease.Mitochondrial disease: clinical aspects, molecular mechanisms, translational science, and clinical frontiers.Near-complete elimination of mutant mtDNA by iterative or dynamic dose-controlled treatment with mtZFNs.Mitochondrial DNA Heteroplasmy Associations With Neurosensory and Mobility Function in Elderly Adults.EENdb: a database and knowledge base of ZFNs and TALENs for endonuclease engineeringMitochondrial targeting of recombinant RNAs modulates the level of a heteroplasmic mutation in human mitochondrial DNA associated with Kearns Sayre SyndromeModifying the Mitochondrial Genome.Emerging therapies for mitochondrial disorders.Selective removal of deletion-bearing mitochondrial DNA in heteroplasmic Drosophila.Targeted approaches for gene therapy and the emergence of engineered meganucleases.Mitochondrially targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large-scale deletions or point mutations.The approaches for manipulating mitochondrial proteomeTowards artificial metallonucleases for gene therapy: recent advances and new perspectives.Genome modifications in plant cells by custom-made restriction enzymes.Transgenic chickens.Nuclease-mediated genome editing: At the front-line of functional genomics technology.Emerging aspects of treatment in mitochondrial disorders.Gene editing technology as an approach to the treatment of liver diseases.Engineering and optimising deaminase fusions for genome editing.MitoTALEN: A General Approach to Reduce Mutant mtDNA Loads and Restore Oxidative Phosphorylation Function in Mitochondrial Diseases.Targeting individual subunits of the FokI restriction endonuclease to specific DNA strands.Assembly and in vitro functional analysis of zinc finger nuclease specific to the 3' untranslated region of chicken ovalbumin gene.Scientific opinion addressing the safety assessment of plants developed using Zinc Finger Nuclease 3 and other Site-Directed Nucleases with similar functionMitochondrial Genome Engineering: The Revolution May Not Be CRISPR-Ized.Applications of Alternative Nucleases in the Age of CRISPR/Cas9.Mitochondrial Haplotype Alters Mammary Cancer Tumorigenicity and Metastasis in an Oncogenic Driver-Dependent Manner.Continuous genetic recording with self-targeting CRISPR-Cas in human cells.Precision genetic modifications: a new era in molecular biology and crop improvement.
P2860
Q24650545-85F74343-E5D3-4F74-94B7-3123F0FF694AQ26752831-4589546A-9A39-4B88-B5F1-139263A80C95Q27005350-97A83A42-8FA2-4996-80AA-363B80E053E2Q28085748-E8A0A76D-75F3-4E26-89D0-84D3388F713BQ33622931-0B5F1608-4A7E-4182-AB26-651B58EE5B2BQ34127971-CCA01742-38BB-4A23-835E-117EF0B244C3Q34156841-3BD52F08-57E8-4A1A-A4E5-EB8A1BA54DEFQ34205124-E164FF2E-D391-4154-88E8-03D7405488E7Q34473537-C2E27F53-F3D4-41BA-8671-3E5283780E13Q34758002-E090B2EC-5D33-4306-A016-D3D906F8B98DQ35066611-FBCC2F42-DF79-48C3-9AE8-19B66E7F36FAQ35069388-93A7066C-A07C-4F7B-8C65-635FEA14DA61Q35219897-4AC4CA3D-C7C2-4FA7-A9DD-65DD13C488FAQ35997215-3415EC2F-DE19-42DC-9DB0-D20C7B488320Q36088172-BF8224C2-3F6C-4DDA-8C9C-194C00E425D3Q36181516-2D8FE48A-64D1-495F-92DC-87A8C48FDBADQ36491274-D219B72C-39FA-4835-8F65-39BEA6EDFB7DQ36668719-60BB925D-24AB-4191-960B-407094D2BC6EQ36894373-3173798B-2EB3-4CF1-A3B1-CF90604AA489Q36967723-0927C1A8-0FE1-4027-A7E0-784BA3EB5FE3Q37421594-F807369E-1A4D-45E5-AEA8-82B356FF7668Q37581606-2CDFEB26-C527-409C-899C-7A313C53ECBBQ37710809-BCDF2033-3086-4DEA-9C28-5B484D08D0AFQ37764798-667711A9-1330-46C1-95B0-570C7F906C08Q37948867-BA374C27-22EE-4D96-93F5-3518DCFE13BFQ37999109-AFC62EB5-6A0F-4999-830B-BC7ACCA1D21FQ38070692-AF3CCAB4-B20E-4776-9FB8-D5A24544ED49Q38175498-EF54749D-1D1B-4DAF-919E-B927C4B531DAQ38472989-C1CE99C4-8361-4FA3-8B4F-EC0C4BCE181BQ38749884-D713A69A-B135-41F4-BE9F-3EB9AF1B0454Q38800431-9366E3C6-28AF-4F4A-89D2-63B8BD4DF43FQ38854973-492057AA-BFD3-441E-82E4-9C0400ED9F43Q43141069-7E26D5A9-FF36-47CD-93DE-F21979CC86F6Q44095245-F8B58CD0-941C-4748-AA8F-D9D3D3CBDEB3Q47152423-5211E514-27F1-41CB-B7E5-1792BFEDE6B5Q47309962-80380B3C-CA37-4DA6-A735-75F8D79A7141Q47352665-809EF4AB-7B3F-44FA-B9BD-205AB596DF6FQ47598716-92749533-9015-40C9-BC21-FEFF7C2D868EQ48601126-5DF4E3E8-6549-4FFB-927F-FF7A34888E54Q52422942-D0B9ABD4-DF4F-4B90-8FB0-CF9379DC37EE
P2860
Development of a single-chain, quasi-dimeric zinc-finger nuclease for the selective degradation of mutated human mitochondrial DNA.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Development of a single-chain, ...... tated human mitochondrial DNA.
@en
Development of a single-chain, ...... tated human mitochondrial DNA.
@nl
type
label
Development of a single-chain, ...... tated human mitochondrial DNA.
@en
Development of a single-chain, ...... tated human mitochondrial DNA.
@nl
prefLabel
Development of a single-chain, ...... tated human mitochondrial DNA.
@en
Development of a single-chain, ...... tated human mitochondrial DNA.
@nl
P2093
P2860
P356
P1476
Development of a single-chain, ...... tated human mitochondrial DNA.
@en
P2093
Aaron Klug
Jeffrey C Miller
Michal Minczuk
Monika A Papworth
P2860
P304
P356
10.1093/NAR/GKN313
P577
2008-05-29T00:00:00Z